CHA.32223
Hydroxyapatite granules
--
--
Ordering
Available Variants25 g
CHA.32223-25g
Price
€155.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 g | CHA.32223-25g | €155.20 |
0.5-1.0 mm grain size
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Linear Formula | Ca10(PO4)6(OH)2 |
|---|---|
| NACRES | NA.23 |
| UNSPSC Code | 12352305 |
Safety Information Handling visibility
| Storage Class | 13 - Non Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Hydroxyapatite granules, with a CAS number of 12167-74-7, are a form of calcium phosphate that is widely used in various biomedical applications due to its similarity in composition to the mineral component of bone tissue. The granules are typically synthesized through a precipitation reaction and can be tailored to have specific particle sizes and morphologies. Hydroxyapatite granules have been shown to be biocompatible and osteoconductive, making them suitable for use as bone graft substitutes and in tissue engineering scaffolds. They can also be used as carriers for drugs, growth factors, and other bioactive molecules, allowing for controlled release and targeted delivery. The use of hydroxyapatite granules has been explored in a range of medical applications, including orthopedic, dental, and maxillofacial surgery, where they have been shown to promote bone regeneration and healing.
